Antibody Sequence Prediction Using Evolution-Aware Language Model

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibody representation learning methods face challenges in accurately predicting antibody sequences due to the lack of a reliable benchmark for performance evaluation and insufficient extraction of biological information, as they treat amino acid sequences as text without considering antibody-specific characteristics.

Innovation Solution

The method involves obtaining an antibody sequence and its germline sequence, using evolution information and mutation positions to determine prediction results, employing an evolution-aware antibody language model (EATLM) that incorporates transformer encoders to analyze B-cell classification, disease classification, and antigen binding predictions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If antibody sequences are treated as text for representation learning, then large-scale pre-training can be performed on massive unlabeled sequences, but the method fails to extract accurate biological information and achieve reliable prediction performance

Engineering Contradiction:
Improveprocessing capacity for large-scale sequencesVSAvoidprediction accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent changes the parameter representation from generic text tokens to antibody-specific parameters including germline sequence information, mutation positions, and evolutionary relationships. This allows the model to process large-scale sequences while capturing biologically meaningful features that improve prediction accuracy.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces germline sequences as an intermediary element that mediates between the raw antibody sequence and the prediction task. By comparing antibody sequences to their germline counterparts, the model extracts evolution information and mutation patterns that serve as biologically relevant features for accurate prediction.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If generic text-based language models are used for antibody analysis, then implementation is straightforward, but the models cannot capture antibody-specific biological characteristics and evolutionary information

Engineering Contradiction:
Improvemodel implementation simplicityVSAvoidbiological information extraction accuracy
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies local quality by introducing antibody-specific processing modules within the transformer architecture. These modules locally process germline sequences, mutation positions, and evolutionary relationships, allowing the model to maintain overall simplicity while capturing localized biological features critical for reliable prediction.

Inventive Principle:
Principle #3Local quality

3Measurement precision

If evolution information and mutation positions are incorporated into the analysis, then prediction accuracy improves, but the computational complexity and data processing requirements increase

Engineering Contradiction:
Improveprediction accuracyVSAvoidmodel structure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-processing antibody sequences to identify and encode germline sequences, mutation positions, and evolutionary relationships before inputting them to the transformer model. This preparation step organizes complex biological information into structured formats that the model can efficiently process, reducing computational complexity during the main prediction task.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20230343412A1Method, device, and medium for result prediction for antibody sequence
Publication Date: 2023.10.26 BEIJING YOUZHUJU NETWORK TECH CO LTD
  • US20230343412A1 patent drawing
  • US20230343412A1 patent drawing
  • US20230343412A1 patent drawing

AI summary

Systems and methods directed to providing a method for determining a prediction result related to an antibody sequence. The method comprises obtaining an antibody sequence comprising a plurality of amino acids, and obtaining a germline sequence of the antibody sequence. The method further comprises determining a prediction result related to the antibody sequence based on at least one of: evolution information between the antibody sequence and the germline sequence, or a mutation position on the antibody sequence, wherein an amino acid of the plurality of amino acids mutates on the mutation position.